Regular colds could give children more protection against Covid, scientists say  Telegraph.co.ukView Full coverage on Google News
Researchers find that 44 per cent of under-16s but only five per cent of adults have 'cross-reactive' antibodiesResearchers find that 44 per cent of under-16s but only five per cent of adults have 'cross-reactive' antibodies

Regular colds could give children more protection against Covid, scientists say

A new study suggests that a small portion of the population carries antibodies that respond to the coronavirus behind covid-19 that were created before the pandemic emerged last late year. The research is the latest to indicate that some people may have a degree of preexisting immunity to the coronavirus,...

Some People Already Have Antibodies That Recognise Covid-19, Thanks to Common Colds

Rapid Reviews: COVID-19 (RR:C19), an open-access overlay journal published by the MIT Press that accelerates peer review of COVID-19-related research preprints, is currently soliciting reviews of the following COVID-19 preprints.Rapid Reviews: COVID-19 (RR:C19), an open-access overlay journal published by the MIT Press that accelerates peer review of COVID-19-related research preprints, is currently soliciting reviews of the following COVID-19 preprints.

Reducing the airborne transmission risk for SARS-CoV-2

A new study from the University of Pittsburgh found the nanobodies were many times more effective at neutralizing the virus and were able to save one million cells from being infected.A new study from the University of Pittsburgh found the nanobodies were many times more effective at neutralizing the virus and were able to save one million cells from being infected.

Llamas make tiny 'nanobodies' that are 'many times more powerful' than human coronavirus antibodies | Daily Mail Online

We bring you the latest on the scientific studies and the efforts to find treatments and vaccines for the coronavirusWe bring you the latest on the scientific studies and the efforts to find treatments and vaccines for the coronavirus

COVID-19: What are the latest efforts to find treatment or vaccine?

Today in Science, researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2Today in Science, researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2

Llama Nanobodies Could be a Powerful Weapon Against COVID-19 - ScienceBlog.com

A study from MIT suggests that super-spreading events may be playing a larger role in SARS-CoV-2 transmission than scientists had anticipated.A study from MIT suggests that super-spreading events may be playing a larger role in SARS-CoV-2 transmission than scientists had anticipated.

SARS-CoV-2 transmission: How important is 'super-spreading'?

An experimental nasal spray seems to block the coronavirus for a full 24 hours, potentially giving us a new shield while we wait for vaccines.An experimental nasal spray seems to block the coronavirus for a full 24 hours, potentially giving us a new shield while we wait for vaccines.

If This COVID-Blocking Nasal Spray Works on Humans, It Could Change the Course of the Pandemic

An experimental nasal spray seems to block the coronavirus for a full 24 hours, potentially giving us a new shield while we wait for vaccines.An experimental nasal spray seems to block the coronavirus for a full 24 hours, potentially giving us a new shield while we wait for vaccines.

If This COVID-Blocking Nasal Spray Works on Humans, It Could Change the Course of the Pandemic

Researchers at the Francis Crick Institute and University College London have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target SARS-CoV-2 and may confer a degree of protection against the new viral strain. In response to inf

Some People – Mainly Children – Have Pre-existing Coronavirus Antibodies That Could Help Protect Against COVID-19

The research, from UCL and the Francis Crick Institute, studied antibodies circulating in blood samples taken before the coronavirus pandemic started, dating back to 2011.

Antibodies against the common cold may protect against Covid-19

Scientists at the University of Cambridge, in collaboration with Justus-Liebig University, Germany, have uncovered how the genome of SARS-CoV-2—the coronavirus that causes COVID-19—uses genome origami ...

SARS-CoV-2 uses 'genome origami' to infect and replicate inside host cells

The US Food and Drug Administration (FDA) has given an emergency use authorization to the first commercial laboratory test to detect neutralizing antibodies against SARS-CoV-2, the virus that causes COVID-19.
 

First COVID neutralizing antibody test okayed by FDA | RAPS

According to the study, understanding how long people can remain actively infected is important since it provides new details about Covid that are still not well understood.According to the study, understanding how long people can remain actively infected is important since it provides new details about Covid that are still not well understood.

US Cancer Patient Carried Coronavirus For 105 Days With No Symptoms: Study

SARS-CoV-2, the respiratory virus that causes COVID-19, attacks the body in multiple steps. Gaining entry into cells deep within the lungs and hijacking the human host cell's machinery to churn out copies ...

Study reveals strategy to create COVID-19 drugs to inhibit virus's entry and replication

The researchers concluded that, to their knowledge, the llama nanobodies they isolated and used to eliminate their SARS-CoV-2 samples are the most potent neutraliser to dateThe researchers concluded that, to their knowledge, the llama nanobodies they isolated and used to eliminate their SARS-CoV-2 samples are the most potent neutraliser to date

Llama nanobodies may be extremely effective in neutralising live SARS-CoV-2 virus, reveals study - Health News , Firstpost

Researchers at the Francis Crick Institute and University College London have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target ...

Pre-existing coronavirus antibodies could help protect children against new pandemic strain

Risk and severity of infection, the host and the environment could all play a roleRisk and severity of infection, the host and the environment could all play a role

Why COVID-19 Might Get Worse in Winter, Just Like Flu | MedPage Today

SARS-CoV-2, the virus that causes COVID-19, taps into human proteases such as furin to enter cells. Temporarily inhibiting those enzymes might stymy infection.SARS-CoV-2, the virus that causes COVID-19, taps into human proteases such as furin to enter cells. Temporarily inhibiting those enzymes might stymy infection.

Scientists Probe Blockers for the Coronavirus Spike Protein | The Scientist Magazine®

That is good newsThat is good news

Teed up - The T-cell immune response to covid lasts at least six months | Science & technology | The Economist

The woman was immunocompromised but never developed symptoms of COVID-19. The woman was immunocompromised but never developed symptoms of COVID-19.

Woman with COVID-19 sheds infectious virus for a record 70 days | Live Science

A leukemia patient shed infection of COVID-19 for at least 70 days.A leukemia patient shed infection of COVID-19 for at least 70 days.

Coronavirus patient spread SARS-CoV-2 for 70 days, study says - Deseret News

Many efforts to develop therapies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are focused on the spike (S) protein trimer that binds to the host receptor. Structures of trimeric S protein show its receptor-binding domain in either an up or a down conformation. Toelzer et al. produced SARS-CoV-2 S in insect cells and determined the structure by cryo–electron microscopy. In their dataset, the closed form was predominant and was stabilized by binding linoleic acid, an essential fatty acid. A similar binding pocket appears to be present in previous highly pathogenic coronaviruses, and past studies suggested links between viral infection and fatty acid metabolism. The pocket could be exploited to develop inhibitors that trap S protein in the closed conformation. Science , this issue p. [725][1] Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents a global crisis. Key to SARS-CoV-2 therapeutic development is unraveling the mechanisms that drive high infectivity, broad tissue tropism, and severe pathology. Our 2.85-angstrom cryo–electron microscopy structure of SARS-CoV-2 spike (S) glycoprotein reveals that the receptor binding domains tightly bind the essential free fatty acid linoleic acid (LA) in three composite binding pockets. A similar pocket also appears to be present in the highly pathogenic severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). LA binding stabilizes a locked S conformation, resulting in reduced angiotensin-converting enzyme 2 (ACE2) interaction in vitro . In human cells, LA supplementation synergizes with the COVID-19 drug remdesivir, suppressing SARS-CoV-2 replication. Our structure directly links LA and S, setting the stage for intervention strategies that target LA binding by SARS-CoV-2. [1]: /lookup/doi/10.1126/science.abd3255

Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein | Science

Children and adults produce different types and amounts of antibodies in response to infection with the new coronavirus, SARS-CoV-2, a new study from researchers at Columbia University Vagelos College ...

Children produce different antibodies in response to SARS-CoV-2

Scientists have found a new method to extract tiny but extremely powerful novel coronavirus antibody fragments from llamas, which they say could be fashioned into inhalable therapeutics with the potential to prevent and treat Covid-19. These special llama antibodies, called nanobodies, are much smaller than human antibodies, according to the researchers from the University ofScientists have found a new method to extract tiny but extremely powerful novel coronavirus antibody fragments from llamas, which they say could be fashioned into inhalable therapeutics with the

Novel inhalable llama antibodies may help treat, prevent Covid-19: Study | Deccan Herald

French director of public health on Thursday reported 58,046 new COVID-19 infections over the past 24 hours, setting a daily record for the second time in four days, versus 40,558 on Wednesday.French director of public health on Thursday reported 58,046 new COVID-19 infections over the past 24 hours, setting a daily record for the second time in four days, versus 40,558 on Wednesday.

France reports new record daily COVID-19 cases, at more than 58,000 | Reuters

Among people who were never infected with the new coronavirus, a few adults - and many children - may have antibodies that can neutralize the virus, researchers reported in Science.Among people who were never infected with the new coronavirus, a few adults - and many children - may have antibodies that can neutralize the virus, researchers reported in Science.

Common cold antibodies hold clues to COVID-19 behavior: Researchers

Researchers discovered a COVID-19 patient who shed the novel coronavirus for 70 days without showing any symptoms during the period. The patient suffered from a form of leukemia, which might explain why the immune system could not mount a proper response that would have cleared the virus.Researchers discovered a COVID-19 patient who shed the novel coronavirus for 70 days without showing any symptoms during the period. The patient suffered from a form of leukemia, which might explai…

Startling discovery reveals an asymptomatic coronavirus patient was contagious for 70 days – BGR

Researchers from Columbia University say the findings could explain why children tend to experience less severe infection than adults Researchers from Columbia University say the findings could explain why children tend to experience less severe infection than adults

Coronavirus: Children and adults produce different antibodies in response to SARS-CoV-2 - Mirror Online

Certain COVID-19 patients not only recover faster from the coronavirus, but their bodies also show longer-lasting immunity, according to a new study.Certain COVID-19 patients not only recover faster from the coronavirus, but their bodies also show longer-lasting immunity, according to a new study.

Some COVID Patients See Faster Recovery, More Immunity

A nasal spray that attacks the coronavirus has been found to protect a small group of ferrets, raising hopes that the solution might do the same for humans. The spray is inexpensive to make and does not... Health News Summaries. | NewserIt's found to 'completely' protect ferrets in small study

Nasal Spray Study Raises Hopes for COVID Protection

The case contradicts the COVID-19 guidelines issued by America’s Centers for Disease Control and Prevention (CDC) that state that immunocompromised coronavirus patients are not likely to remain infectious after 20 days. The case contradicts the COVID-19 guidelines issued by America’s Centers for Disease Control and Prevention (CDC) that state that immunocompromised coronavirus patients are not likely to remain infectious after 20 days.

Asymptomatic COVID-19 patient in US carried virus for over 70 days

Special llama antibodies called nanobodies is the most effective way to fight COVID-19, so far. On Thursday, the University of Pittsburgh School of Medicine Special llama antibodies called nanobodies is the most effective way to fight COVID-19, so far. On Thursday, the University of Pittsburgh School of Medicine hosted an online news conference to discuss the research published in “Science” magazine that describes a new method to extract tiny, but extremely powerful SARS-CoV-2 antibody fragments from llamas, which could […]

Llama Nanobodies Most Potent Weapon To Fight COVID | News, Sports, Jobs - Post Journal

Access Denied

A study that has yet to be peer-reviewed showed promise in protecting ferrets from contracting the new novel coronavirus.A study that has yet to be peer-reviewed showed promise in protecting ferrets from contracting the new novel coronavirus.

Nasal spray prevents COVID-19 infection in test animals, new study finds | TheHill

A study that has yet to be peer-reviewed showed promise in protecting ferrets from contracting the new novel coronavirus.A study that has yet to be peer-reviewed showed promise in protecting ferrets from contracting the new novel coronavirus.

Nasal spray prevents COVID-19 infection in test animals, new study finds | TheHill

Children more efficient in tackling Sars-CoV-2, scientists from New York findChildren more efficient in tackling Sars-CoV-2, scientists from New York find

Coronavirus: Children produce weaker immune response, study shows | The Independent

'If it works this well in humans, you could sleep in a bed with someone infected or be with your infected kids and still be safe.'

Study shows nasal spray could stop spread of coronavirus, report says - silive.com

Researchers have discovered a way to extract “tiny but extremely powerful SARS-CoV-2 antibody fragments from llamas,” according to a new study.A llama named Wally may hold the key in the fight against the coronavirus, according to a new study. Researchers have discovered a way to extract “tiny but extremely powerful SARS-CoV-2 antibody

Llama 'nanobodies' are powerful new COVID-19 treatment: study

A 71-year-old coronavirus patient in the US was contagious for more than two months even as she showed no symptoms of the Covid-19 infection. The woman was also suffering from cancer which had weakened her immune system. The case contradicts the guidelines of the CDC, which say that "immunocompromised" Covid-19 patients are likely not infectious after 20 days.A 71-year-old coronavirus patient in the US was contagious for more than two months even as she showed no symptoms of the Covid-19 infection. The woman was also suffering from cancer which had weakened her immune system. The case contradicts the guidelines of the CDC, which say that "immunocompromised" Covid-19 patients are likely not infectious after 20 days.

Asymptomatic coronavirus patient in US remains contagious for 70 days, contradicting CDC findings - Coronavirus Outbreak News

The key to ending the global COVID-19 pandemic may be a llama named Wally.

Wally the llama may be key to treating COVID-19 | Canoe.Com

Wally the llama may be key to treating COVID-19 | Canoe.com

The research suggests that children clear the infection much faster than adults and may help explain why many don’t become seriously ill.The research suggests that children clear the infection much faster than adults and may help explain why many don’t become seriously ill.